The 19th CROI: ARV Therapies and Therapeutic Strategies

NEW_CROI-2012_eSymposium_Web_banner.jpg 

2012_CROI_OnDemand.jpg

2012_CROI_Spanish_OnDemand.jpg

2012_CROI_French_OnDemand.jpg

2012_CROI_SlidePresentation.jpg

2012_CROI_Newsletter.jpg

2012_CROI_PosterReview.jpg

About the Program

Program Overview

This 1.5-hour Internet symposium will review and discuss the key studies on antiretroviral therapy presented at the 19th Conference on Retroviruses and Opportunistic Infections. The symposium will feature five well-known and recognized thought leaders in the HIV field, with four serving as presenting faculty/discussants and one as program moderator.

This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine.  


Back to Top   

Target Audience

This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.

Back to Top

Learning Objectives

After completing this activity, participants should be able to:

  • Explain the key new studies on ARV therapy presented at the 19th CROI; 
  • Outline how to use the advances in clinical management of HIV-positive patients presented and discussed at the 19th CROI to improve patient care;
  • Describe how to apply data presented at the 19th CROI regarding the treatment of ARV-naïve and experienced patients;
  • Construct appropriate ARV regimens for HIV-positive patients;
  • Apply information on newer therapies in therapeutic discussions.

Release Date: March 16, 2012

Expiration Date: March 16, 2013

Estimated time to complete the CROI 2012 Web Symposium: 1 hour, 30 minutes

Media: Internet

Back to Top

Course Director and Moderator

John Bartlett, MD
Professor, Johns Hopkins University
School of Medicine
Baltimore, Maryland

Faculty

José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain

Calvin J. Cohen, MD, MS
Research Director, CRI New England
Clinical Instructor, Harvard Medical School
Boston, Massachusetts

David Cooper, MD
Professor, University of New South Wales
Director of The National Centre in Epidemiology & Clinical Research
Sydney, Australia

Jürgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany 

Back to Top  

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.   

Back to Top

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Postgraduate Institute for Medicine is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dr. Jose Arribas:

  • Consulting Fees: Merck & Co.; Abbott; Tibotec; Janssen; Gilead; GlaxoSmithKline; Pfizer; Biogen; Avexa; Bristol-Myers Squibb; ViiV

Dr. John Bartlett:

  • Nothing to Disclose 

Dr. Calvin Cohen:

  • Contracted Research: Gilead; Bristol-Myers Squibb; Merck; Janssen
  • Consulting Fees: Gilead; Bristol-Myers Squibb; Janssen; Merck; Tobira 

Dr. David Cooper:

  • Consulting Fees: ViiV; Gilead; Merck & Co.; Tobira; Bristol-Myers Squibb; Tibotec

Dr. Juergen Rockstroh:

  • Contracted Research: Abbott; Merck & Co.; Roche
  • Consulting Fees: Abbott; Bristol-Myers Squibb; BI; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead; Tibotec; ViiV

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Shultz, RN, MSN, CCMEP and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine (PIM), ViralEd, Inc. and Merck & Co. do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, ViralEd, Inc. and Merck & Co. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the period, Date March 16, 2012 through March 16, 2013, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

You may complete the Post-test on-line at www.cmeuniversity.com

  • Click on "Find Post-Test/Evaluation by Course" on the navigation menu
  • Search by project ID: 8756
  • Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately. 

Disclaimer 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Back to Top

PIM_small

 Supported by an educational grant from Merck & Co., Inc.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings


s
Prepare to print

Share this page:

Get link code to this page     


Back to Top